Fisher & Paykel Healthcare Corporation Limited
NZ$47.66+NZ$0.28 (+0.59%)
Fisher & Paykel Healthcare Corporation Limited’s quoted price sits in the upper half of its reported 52-week range, 3.97% below the high.
NZE · SUM.NZ · NZD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 04:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · NZD. Historical prices are not a forecast.
Summerset Group Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 48.75% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Summerset Group Holdings Limited’s forward annual dividend is NZ$0.08 per share, paid semi-annual. The forward yield is 1.16% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Summerset Group Holdings Limited’s next earnings report is currently expected on Feb 24, 2027, with estimated earnings per share of NZ$0.41. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Summerset Group Holdings Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Summerset Group Holdings Limited, along with its various subsidiaries, is engaged in the creation, ownership, and management of comprehensive retirement communities throughout New Zealand and Australia. These communities offer a full spectrum of care options, including residential aged care, hospital care, specialized memory care, and both temporary respite and short-stay services. For residents, accommodation choices are extensive, ranging from villas, cottages, and townhouses to diverse apartment types, including serviced units, as well as dedicated care centers. The company also undertakes the development of land specifically for these senior living projects. Currently, Summerset develops and operates 29 such villages, housing approximately 6,900 individuals. Established in 1997, the company's corporate headquarters are situated in Wellington, New Zealand, and it functions as a subsidiary of New Zealand Central Securities Depository Limited.
Latest available per-share figures in NZD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:20 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Apr 24, 2024 |
| NZ$1.30 |
| NZ$143.18M |
| Q2 2023 | Aug 21, 2023 | NZ$0.57+67.16% vs estimate | NZ$127.32M-40.56% vs estimate |
|---|
| Q4 2022 | Feb 23, 2023 | NZ$0.58 | NZ$215.20M-35.4% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NZ$47.66+NZ$0.28 (+0.59%)
Fisher & Paykel Healthcare Corporation Limited’s quoted price sits in the upper half of its reported 52-week range, 3.97% below the high.
NZ$1.77+NZ$0.03 (+1.72%)
Ryman Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 41.97% below the high.
NZ$4.65-NZ$0.05 (-1.06%)
AFT Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 4.12% below the high.
NZ$0.64-NZ$0.01 (-1.54%)
Oceania Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 31.18% below the high.
NZ$1.31+NZ$0.01 (+0.77%)
Winton Land Limited’s quoted price sits in the lower half of its reported 52-week range, 43.53% below the high.
NZ$0.39NZ$0.00 (0.0%)
Radius Residential Care Limited’s quoted price sits in the lower half of its reported 52-week range, 20.41% below the high.
NZ$4.20-NZ$0.13 (-3.0%)
Third Age Health Services Limited’s quoted price sits in the lower half of its reported 52-week range, 43.78% below the high.
NZ$0.67NZ$0.00 (0.0%)
Promisia Healthcare Limited’s quoted price sits in the upper half of its reported 52-week range, 15.19% below the high.